The STK32C antibody targets the serine/threonine kinase 32C (STK32C), a member of the STK kinase family involved in regulating diverse cellular processes. STK32C, also known as YANK3. contains a conserved kinase domain and is part of the YANK (Yet Another Kinase) subfamily, which includes STK32A and STK32B. While its precise biological functions remain under investigation, STK32C is implicated in cell signaling pathways, cytoskeletal organization, and cellular polarity. Studies suggest potential roles in neural development, as it is enriched in brain tissues, and possible links to cancer due to kinase-mediated signaling dysregulation. The STK32C antibody is primarily utilized in research to detect protein expression, localization, and post-translational modifications via techniques like Western blotting, immunohistochemistry, and immunofluorescence. Its development aids in exploring STK32C's interactions with substrates or binding partners, shedding light on its regulatory mechanisms. Although not yet widely characterized compared to other kinases, STK32C's conserved structure and tissue-specific expression highlight its potential as a biomarker or therapeutic target. Current research focuses on elucidating its physiological relevance in health and disease, particularly in neurological disorders and oncogenesis.